Your Health Questions
Answered by Professionals

There are several factors to consider if your UC is still flaring despite treatment, including a poor medication fit, secondary loss of response, persistent inflammation, or non-UC causes like infection or IBS overlap. Next steps often include objective reassessment and either optimizing current therapy or switching classes, including discussing oral JAK inhibitors for UC such as tofacitinib or upadacitinib with appropriate screening and monitoring. Key safety considerations, red flag symptoms, and guidance on tests, drug levels, clinical trials, and when surgery is appropriate are detailed below, which can significantly influence the best path forward with your care team.

Persistent IBD flares despite medication often happen because the drug is targeting the wrong immune pathway, levels are too low or blocked by antibodies, there is fixed scarring, or symptoms are from non inflammatory conditions like IBS, bile acid diarrhea, SIBO, or infection. There are several factors to consider; see below to understand more, including precision medicine steps like therapeutic drug and antibody monitoring, treat to target biomarkers, earlier and better matched biologic or small molecule options, nutrition support, and when to seek urgent care, with key details and next step questions for your doctor outlined below.

Persistent ulcerative colitis flares despite microbiome therapy often mean active inflammation is still driving disease, the probiotic strains or doses are ineffective, diet and stress are undermining progress, or you need combination therapy with standard UC medications rather than microbiome approaches alone. Evidence based next steps include therapeutic drug monitoring, switching biologic classes, considering JAK or S1P inhibitors, and evaluating FMT or clinical trials, while watching for red flag symptoms that need urgent care. There are several factors and tests that can change your plan, see the complete details below.

IBD trials with no placebo group ensure every participant receives active treatment, which can be more ethical and practical for people still flaring after standard therapies, while also offering access to emerging drugs and closer monitoring. There are several factors to consider, including that these options are investigational, side effects and eligibility vary, and designs may compare new treatments to approved drugs or different doses, so see the details below to learn risks, who might be a candidate, and how to discuss next steps with your gastroenterologist.

Persistent IBD flares on a single medication are common and often reflect multi-pathway inflammation, loss of response from antibodies or low drug levels, and high-risk disease that can outpace monotherapy. There are several factors to consider. High-quality trials like SONIC and UC SUCCESS show that Combination therapy IBD, usually a biologic plus an immunomodulator, improves steroid-free remission and mucosal healing compared with monotherapy, though added infection risk and other tradeoffs mean decisions must be individualized within a treat-to-target plan; see below for who benefits, safety details, and next steps to discuss with your gastroenterologist.

Crohn’s flares can persist because inflammation and structural damage are different problems; biologics target inflammation while surgery removes strictures or fistulas, and new data show early, localized surgery can match biologics for remission and quality of life, with many patients doing best when the two are combined. There are several factors to consider; see below to understand how disease location, scar tissue, fistulas or abscesses, drug levels, imaging, and smoking status guide whether to switch biologics, add surgery, use both, or seek urgent care, which could change your next steps.

IBD mucosal healing often stalls when inflammation persists despite symptom relief, the treatment is not the right fit or taken inconsistently, or hidden triggers like NSAIDs, smoking, stress, infections, and nutrient or protein deficits slow repair. Fastest routes to repair include optimized targeted therapy such as biologics or JAK inhibitors with therapeutic drug monitoring, objective tracking with fecal calprotectin, CRP, and colonoscopy, plus nutrition support and trigger reduction. There are several factors to consider, so see the complete details below to understand what could change your next steps.

If five antidepressants have not helped, this often means treatment-resistant depression, but it is not untreatable and may be driven by factors like misdiagnosis, medical conditions, inflammation, sleep disorders, or genetic differences in how you process meds. See below for critical details that can shape your next steps. Effective next moves include a full re-evaluation plus evidence-based options such as augmentation strategies, ketamine or esketamine, TMS, ECT, intensive psychotherapy, and targeted lifestyle supports; seek urgent help right away if you have suicidal thoughts.

Vagus nerve stimulation for IBD trials is a promising, nerve targeted approach that engages the brain gut axis to lower inflammation without broadly suppressing immunity, with early small studies in Crohn’s and ulcerative colitis showing reduced inflammatory markers, symptom relief, and some remissions using implanted or noninvasive devices, though it remains investigational. There are several factors to consider. See below to understand more about candidacy, potential side effects and surgical risks, access and insurance, and how to talk with your gastroenterologist about trial options that could shape your next steps.

If you are still having IBD symptoms despite treatment, IBD patient registries that track real-world outcomes over years can pinpoint which therapies sustain remission, support treat-to-target personalized care, improve safety monitoring, and reveal fixable gaps that lead to better results. There are several factors to consider, including when to recheck inflammation with labs or imaging, adjust dosing or combinations, check drug levels, address IBS overlap, or seek urgent care for red flags; see below for specific questions to ask your doctor and other key details that could change your next steps.

There are several factors to consider; see below for crucial details. Persistent symptoms despite IBS meds often mean the problem is Crohn’s, especially fistulizing disease that IBS drugs cannot heal, with red flags like rectal drainage, perianal infections, bleeding, weight loss, or nighttime diarrhea. Effective relief now centers on biologics as first line, sometimes with immunomodulators or antibiotics plus surgical help or newer options like stem cell therapy, alongside nutrition support and stopping smoking, and the details below can help you choose next steps and know when to seek urgent care.

If your IBS pain, bloating, constipation, or diarrhea persists, treatments often fail because they are mismatched to your subtype, target symptoms instead of triggers, and ignore gut brain factors, food sensitivities, and overlapping conditions. There are several factors to consider. Medically proven next steps include confirming the diagnosis and red flags, matching therapy to your IBS subtype, using a layered plan that combines gut brain therapies with targeted meds and strategic low FODMAP reintroduction, and assessing the microbiome and overlapping conditions. See below for the complete guidance that can impact which next steps you take.

There are several factors to consider if you are still in pain with suspected or confirmed Crohn’s: the diagnosis may be incomplete or incorrect, inflammation may be uncontrolled despite treatment, or complications like strictures, fistulas, abscesses, or malnutrition may be driving symptoms. See below for a step by step plan to get a Crohn’s second opinion, which tests and labs to review or repeat, how to optimize medications with an IBD specialist, urgent red flags that need immediate care, and the nutrition and mental health supports that can shape your next steps.

Why is cetirizine hydrochloride not stopping my itch? Cetirizine often fails when the itch is not histamine-driven, the dose or timing is suboptimal, triggers are physical, or you have chronic urticaria. Medically approved next steps include: - Supervised dose increases (up to fourfold) or switching antihistamines - Adding an H2 blocker or leukotriene inhibitor - Short steroid courses or biologics like omalizumab - Targeted treatment for eczema or dermatitis - Reviewing other medications that may contribute Seek urgent care for breathing trouble, throat swelling, severe dizziness, or fainting. Because persistent itch can stem from many overlapping causes—and the right treatment depends on pinpointing the underlying trigger—it's worth getting a clearer picture before your next doctor's visit. Take a free, instant, online <a href="https://ubiehealth.com/symptom-checker">symptom check</a> to better understand what's driving your itch and confidently navigate your next steps. Reviewed for medical accuracy: 06/25/2026

There are several factors to consider. For treatment-resistant depression, ECT offers faster relief with higher response rates of about 70 to 90 percent and is preferred for severe or urgent cases, while TMS shows about 50 to 60 percent response, is outpatient without anesthesia, and avoids memory problems. Your best choice depends on severity, urgency, side effect preferences, and practical issues like time and insurance. See the detailed pros and cons, safety notes, maintenance options, and urgent warning signs below to guide your next steps with your clinician.

Persistent sadness despite therapy and medication can reflect the brain needing more time, a mismatched drug, treatment-resistant depression, unrecognized medical issues, trauma needing specialized care, or sleep and lifestyle factors. See below for key details that can change which next steps are right for you. Next steps include a medication review if there is no improvement after 6 to 8 weeks, basic labs for thyroid, B12, D, and iron, reassessing therapy fit or trying structured CBT or trauma-focused work, discussing advanced options like TMS or esketamine, optimizing sleep and alcohol use, and seeking urgent help for any suicidal thoughts.

Dual diagnosis bipolar and addiction needs new, integrated medical steps that treat both at once. Coordinated care with mood stabilization first, addiction treatment tailored to bipolar, protected sleep routines, and vigilant suicide risk monitoring outperforms separated approaches. There are several factors to consider; see below for urgent warning signs, specific medication and therapy options, how to access integrated programs, and practical next steps that could change your care plan.

Exercise alone is not a treatment for bipolar; it can aid mood, sleep, and stress, but symptoms often persist without a comprehensive medical protocol that includes mood stabilizing medication, strict sleep regulation, structured psychotherapy, and close monitoring. There are several factors to consider, including that high intensity workouts can trigger mania and that timing and consistency of exercise matter. See below for the complete plan, specific medication and therapy options, safer exercise guidance, warning signs that require urgent care, and next steps to take with your clinician.

Bipolar treatment is moving toward personalized, preventive care that uses precision psychiatry to guide medications, refined brain stimulation options, digital early warning systems, and targeted psychotherapy plus sleep and routine stabilization. There are several factors to consider, including suicide risk management, subtyping, and earlier detection, and while there is no single cure, sustained, coordinated care can improve stability. See below for specific protocols, emerging options like ketamine, anti inflammatory and metabolic approaches, and long acting injectables, along with next steps to discuss with your clinician.

There are several factors to consider if bipolar symptoms persist after appropriate treatment; see below to understand more. Treatment resistance typically means symptoms continue after at least two adequate medications, and next steps can include optimizing mood stabilizers like lithium, adding atypical antipsychotics, reassessing for coexisting or misdiagnosed conditions, and considering ECT, ketamine or esketamine, TMS, and structured psychotherapy while protecting sleep and other routines. For urgent warning signs like suicidal thoughts, severe agitation, or psychosis, seek immediate care, and see the detailed plan below to decide which options fit your situation.

If symptoms persist despite medication and therapy, a holistic evidence-based plan that adds sleep and social rhythm stabilization, nutrition, steady exercise, stress reduction, substance-use support, and medical screening can reinforce mood stability, reduce relapse risk, and improve quality of life while complementing, not replacing, psychiatric care. There are several factors to consider, including tracking early warning signs and knowing when to seek urgent help, which can shape your next steps. See complete details below.

New antipsychotics offer more targeted treatment when older drugs are not enough, using partial dopamine agonism and effects on multiple neurotransmitters, plus long acting injectables that improve adherence and may better address persistent positive, negative, and cognitive symptoms with fewer movement side effects. There are several factors to consider for next steps, including a medication review, adherence options like injectables, lab monitoring, adding therapy, addressing sleep and substances, and considering clozapine if treatment resistant; see below for expert details, urgent warning signs, and nuances that could change your plan.

Newest FDA approved treatments for depression in 2026 include rapid-acting NMDA-targeting options like esketamine and the oral dextromethorphan-bupropion combo, plus expanded device-based care such as TMS and updated VNS that offer faster relief and new brain targets for people who have not improved with prior antidepressants; tightly regulated psychedelic-inspired care is also emerging. There are several factors to consider, including eligibility, safety monitoring, access and cost, insurance coverage, and how to combine these with therapy for best results. See the complete details below to guide your next steps.

If you are still struggling despite traditional treatment, there are several factors to consider. Next generation bipolar drugs provide more targeted mechanisms, better coverage of bipolar depression, and often improved tolerability, spanning newer atypical antipsychotics, dopamine and serotonin stabilizers, glutamate-modulating options, and long-acting injectables. See below to understand more, including who should consider a switch, key side effects and monitoring, adherence supports, and how combining medication with therapy and structured routines can guide your next steps.

The FDA pipeline for bipolar disorder is active and bringing tangible breakthroughs, from rapid-acting options for bipolar depression that work via glutamate pathways to long-acting injectables that improve adherence, targeted treatments for mixed episodes, and newer agents with fewer metabolic side effects, plus novel approaches involving inflammation and circadian regulation, with recent approvals already expanding choices. There are several factors to consider when choosing next steps; see below for the complete details that could affect your care, including benefits and risks, urgent warning signs, and how to discuss newer therapies with your clinician or use a symptom check to prepare.

New long-term medical data shows vagus nerve stimulation can deliver growing benefits over 1 to 5 years for treatment-resistant depression, with higher response and remission rates than treatment-as-usual and a possible drop in suicide risk. There are several factors to consider, see below to understand more. It is not a quick fix and requires careful screening and awareness of side effects, and there are also non-implant options being studied, so review the details below to learn who may benefit and what steps to discuss with your clinician.

Refractory bipolar disorder means persistent manic, depressive, hypomanic, or mixed symptoms despite at least two adequate medication trials, often due to misdiagnosis, subtherapeutic dosing or interactions, sleep disruption, rapid cycling or mixed features, substance use, or medical issues like thyroid or vitamin deficiencies. Next clinical steps include optimizing mood stabilizers such as lithium and combination regimens, targeted options for bipolar depression, and advanced treatments like clozapine, ketamine or esketamine, ECT, and TMS, alongside circadian-focused care and evidence-based psychotherapy. There are several factors to consider, with specific labs, safety warnings, and decision pathways detailed below.

There are several reasons your brain can resist mood disorder management, including slow-to-shift brain chemistry, depressive thinking patterns, low energy, stress or trauma, and the need for treatment adjustments and consistency. There are several factors to consider; see below for practical next steps like reassessing your plan with a clinician, starting smaller, protecting sleep, reducing isolation, and knowing urgent warning signs that need immediate care, plus more details that could change which steps you take in your healthcare journey.

Circadian rhythm disruption is a leading, underrecognized cause of ongoing bipolar mood swings; aligning sleep timing, light exposure, and daily routines can lower relapse risk and improve stability. Evidence-based next steps include IPSRT, strict sleep protection with a fixed wake time, carefully supervised light therapy, evening blue-light reduction, medication timing review, and plans for travel and seasonal shifts, with clear guidance on when to seek urgent care. There are several factors to consider that can change your next steps; see below for key details and safety considerations.

Depression biomarkers are measurable signals in your body, including inflammation markers like CRP and IL-6, cortisol and other stress measures, BDNF, neurotransmitters, gut patterns, and related labs such as thyroid or hormone panels, that can explain persistent symptoms when standard care falls short and point to more precise, personalized treatment, even though no single test can diagnose depression yet. There are several factors to consider. See below for the specific biomarkers to discuss with your clinician, how they can guide medication and therapy choices, the urgent red flags that need immediate care, and practical next steps you can start now.